Cellgenix USA

Cellgenix GMBH

UEI
CCYHJN1KNAM6
CAGE
6ZA41
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
International Organization
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
sartorius.com
Founded
1870
Employees
10K-50K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Cellgenix USA's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
GMP FLT-3L, 50 UG, GMP SCF, 50 UG, and GMP TPO, 50 UG. Contract · 75N90022P00025 NIH Clinical Center $20,607
GMP FLT-3L, 50 UG Contract · 75N90021P00738 NIH Clinical Center $29,092
Various cellgenix cytokines reagents. Contract · 75N90021P00581 NIH Clinical Center $51,410
Cellgenix GMP RH GM-CSF CAT no:001012-1000 Contract · 75N93021P00868 National Institute of Allergy and Infectious Diseases $0
GMP FLT-3L, 50 UG, -GMP SCF, 50 UG, and GMP TPO, 50 UG. Contract · 75N90021P00365 NIH Clinical Center $17,113

About Cellgenix USA

Cellgenix USA Cellgenix GMBH Division is a leading global supplier of high quality raw and ancillary materials for the cell and gene therapy market. The company provides various cytokines, growth factors, and other pharmaceuticals to support cell and gene therapy research and development.

Through past prime federal contract awards, Cellgenix USA has provided specialized cell therapy-related pharmaceuticals such as GMP cytokines, growth factors, and interleukins to the National Institutes of Health Clinical Center and National Institute of Allergy and Infectious Diseases. Specific goods provided include FLT-3L, SCF, TPO, GM-CSF, interleukin-4 and other cell therapy reagents, with contract award values ranging from $11,942 to $51,410. The contract awards have been prime contracts with no set aside designations, structured as purchase orders and completed on schedule based on the listed completion dates. Cellgenix USA has established itself as a consistent provider of high quality raw materials to support federal cell and gene therapy research initiatives.

Quick answers

What is Cellgenix USA's UEI?

Cellgenix USA's Unique Entity ID (UEI) in SAM.gov is CCYHJN1KNAM6.

What is Cellgenix USA's CAGE code?

Cellgenix USA's CAGE code is 6ZA41.

What is Cellgenix USA's primary NAICS code?

Cellgenix USA's primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).

Is Cellgenix USA registered in SAM.gov?

Cellgenix USA's SAM.gov registration expired on December 8, 2021.

What is Cellgenix USA's most recent federal award?

Cellgenix USA's most recent federal contract award is GMP FLT-3L, 50 UG, GMP SCF, 50 UG, and GMP TPO, 50 UG (75N90022P00025), from NIH Clinical Center, on November 2, 2021.

On GovTribe

See Cellgenix USA's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors